CD200 and narcolepsy: Using a cell-based immunofluorescence method Ciannoccaro and co-workers found only low levels of IgG antibodies against OX2 in 3 out of 61 patients with narcolepsy, suggesting that autoantibodies against OX2 are uncommon in NT1 patients whose disease is not associated with the Pandemrix vaccination [30].